Partner with FINNCURE
FINNCURE collaborates with pharmaceutical and biotech companies to improve how therapies are delivered.
We integrate partner compounds into our tailored carrier systems designed to improve stability,
bioavailability, and precision, without modifying the compound itself.
About FINNCURE
FINNCURE is a Finnish biotechnology company that was founded to address one of the key challenges in modern medicine: delivering therapeutic compounds to the right cells safely and efficiently. The company develops proprietary synthetic carrier systems designed to improve targeting, cellular uptake, and safety of therapeutic delivery.
By incorporating active pharmaceutical ingredients into the carrier platform, therapeutic compounds can be directed to specific cells and tissues with improved targeting, cellular uptake, and safety.
The proprietary manufacturing technology enables scalable production of carrier particles with exceptional size accuracy and reproducibility. Broad payload compatibility allows solutions to be tailored for diverse medical applications. This also enables new IP for our clients.
Partner Network
FINNCURE works with a broad network of collaborators, stakeholders, and service providers across research, preclinical development, clinical validation, and intellectual property management
The partner network includes:
We are currently seeking pilot collaboration opportunities with pharmaceutical and biotech partners whose therapeutic compounds could benefit from improved targeting, cellular uptake, or safety.
R&D Partnerships
Co-development Programs
Early Validation Projects
Licensing
Start a Conversation
We are actively seeking partners, customers, and investors to advance new therapeutic programs and welcome discussions on collaboration, development, and licensing.
Contact us








